326 related articles for article (PubMed ID: 17277342)
1. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
Wilson JC; Yoon HS; Walker RJ; Eccles MR
Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
[TBL] [Abstract][Full Text] [Related]
2. Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.
Yoshioka K; Hino S; Takemura T; Maki S; Wieslander J; Takekoshi Y; Makino H; Kagawa M; Sado Y; Kashtan CE
Am J Pathol; 1994 May; 144(5):986-96. PubMed ID: 8178947
[TBL] [Abstract][Full Text] [Related]
3. Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome.
Hertz JM; Juncker I; Persson U; Matthijs G; Schmidtke J; Petersen MB; Kjeldsen M; Gregersen N
Hum Mutat; 2001 Aug; 18(2):141-8. PubMed ID: 11462238
[TBL] [Abstract][Full Text] [Related]
4. Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis. Relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen.
Kleppel MM; Kashtan C; Santi PA; Wieslander J; Michael AF
Lab Invest; 1989 Sep; 61(3):278-89. PubMed ID: 2671490
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
6. A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.
Chen N; Pan X; Ren H; Dong D
Chin Med J (Engl); 1998 Sep; 111(9):797-802. PubMed ID: 11155669
[TBL] [Abstract][Full Text] [Related]
7. Immunofluorescence study of type IV collagen alpha chains in epidermal basement membrane: application in diagnosis of X-linked Alport syndrome.
Ding J; Yang J; Liu J; Yu L
Chin Med J (Engl); 1997 Aug; 110(8):584-6. PubMed ID: 9594257
[TBL] [Abstract][Full Text] [Related]
8. Three novel COL4A4 mutations resulting in stop codons and their clinical effects in autosomal recessive Alport syndrome.
Dagher H; Yan Wang Y; Fassett R; Savige J
Hum Mutat; 2002 Oct; 20(4):321-2. PubMed ID: 12325029
[TBL] [Abstract][Full Text] [Related]
9. New form of X-linked dominant hereditary nephritis in dogs.
Lees GE; Helman RG; Kashtan CE; Michael AF; Homco LD; Millichamp NJ; Camacho ZT; Templeton JW; Ninomiya Y; Sado Y; Naito I; Kim Y
Am J Vet Res; 1999 Mar; 60(3):373-83. PubMed ID: 10188823
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular diagnosis of Alport syndrome.
Kashtan CE
Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
[TBL] [Abstract][Full Text] [Related]
11. The clinical spectrum of type IV collagen mutations.
Lemmink HH; Schröder CH; Monnens LA; Smeets HJ
Hum Mutat; 1997; 9(6):477-99. PubMed ID: 9195222
[TBL] [Abstract][Full Text] [Related]
12. Autosomal dominant nephritis with renal failure of non-Alport type: clinical and molecular studies.
Ilan T; Shohat T; Tobar A; Magal N; Yahav M; Halpern GJ; Rechavi G; Shohat M
Isr Med Assoc J; 2001 Jul; 3(7):488-91. PubMed ID: 11791413
[TBL] [Abstract][Full Text] [Related]
13. Severe alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele.
Guo C; Van Damme B; Vanrenterghem Y; Devriendt K; Cassiman JJ; Marynen P
J Clin Invest; 1995 Apr; 95(4):1832-7. PubMed ID: 7706490
[TBL] [Abstract][Full Text] [Related]
14. Detection of COL4A5 gene mutations in Chinese patients with Alport's syndrome.
Pan X; Yan J; Ren H; Zhang W; Shi H; Yu H; Wang C; Hao C; Chen X; Chen N
Nephrol Dial Transplant; 2004 May; 19(5):1123-8. PubMed ID: 14993485
[TBL] [Abstract][Full Text] [Related]
15. Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.
Lemmink HH; Nillesen WN; Mochizuki T; Schröder CH; Brunner HG; van Oost BA; Monnens LA; Smeets HJ
J Clin Invest; 1996 Sep; 98(5):1114-8. PubMed ID: 8787673
[TBL] [Abstract][Full Text] [Related]
16. [Molecular genetics of Alport syndrome].
Yamazaki H; Saito A; Nakagawa Y; Arakawa M
Nihon Rinsho; 1992 Dec; 50(12):3021-6. PubMed ID: 1491454
[TBL] [Abstract][Full Text] [Related]
17. Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome.
Mochizuki T; Lemmink HH; Mariyama M; Antignac C; Gubler MC; Pirson Y; Verellen-Dumoulin C; Chan B; Schröder CH; Smeets HJ
Nat Genet; 1994 Sep; 8(1):77-81. PubMed ID: 7987396
[TBL] [Abstract][Full Text] [Related]
18. Absence of ocular manifestations in autosomal dominant Alport syndrome associated with haematological abnormalties.
Colville D; Wang YY; Jamieson R; Collins F; Hood J; Savige J
Ophthalmic Genet; 2000 Dec; 21(4):217-25. PubMed ID: 11135492
[TBL] [Abstract][Full Text] [Related]
19. The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation.
Hudson BG; Kalluri R; Gunwar S; Weber M; Ballester F; Hudson JK; Noelken ME; Sarras M; Richardson WR; Saus J
Kidney Int; 1992 Jul; 42(1):179-87. PubMed ID: 1635348
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated transfer of type IV collagen alpha5 chain cDNA into swine kidney in vivo: deposition of the protein into the glomerular basement membrane.
Heikkilä P; Tibell A; Morita T; Chen Y; Wu G; Sado Y; Ninomiya Y; Pettersson E; Tryggvason K
Gene Ther; 2001 Jun; 8(11):882-90. PubMed ID: 11423936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
